"Cefotaxime" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Semisynthetic broad-spectrum cephalosporin.
| Descriptor ID |
D002439
|
| MeSH Number(s) |
D02.065.589.099.249.190.190 D02.886.665.074.190.190 D03.633.100.300.249.190.190
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cefotaxime".
Below are MeSH descriptors whose meaning is more specific than "Cefotaxime".
This graph shows the total number of publications written about "Cefotaxime" by people in this website by year, and whether "Cefotaxime" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cefotaxime" by people in Profiles.
-
A novel STK1-targeted small-molecule as an "antibiotic resistance breaker" against multidrug-resistant Staphylococcus aureus. Sci Rep. 2017 07 11; 7(1):5067.
-
Evolvability as a function of purifying selection in TEM-1 ß-lactamase. Cell. 2015 Feb 26; 160(5):882-892.
-
Prediction of major antibiotic resistance in Escherichia coli and Klebsiella pneumoniae in Singapore, USA and China using a limited set of gene targets. Int J Antimicrob Agents. 2014 Jun; 43(6):563-5.
-
Pathogenesis of early operative site infections after orthotopic liver transplantation. Transplantation. 1998 Jun 15; 65(11):1500-3.
-
Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli. Am J Med. 1987 Apr 27; 82(4A):80-6.
-
Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. Clin Ther. 1987; 10 Suppl A:36-49.
-
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model. J Antimicrob Chemother. 1986 Jul; 18(1):51-63.
-
[The effect of ceftriaxone on the blood coagulation parameters of intensive care patients]. Wien Med Wochenschr Suppl. 1985; 87:16-21.
-
Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits. J Antimicrob Chemother. 1985 Jan; 15 Suppl A:207-19.
-
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model. Antimicrob Agents Chemother. 1984 May; 25(5):545-52.